07/17/2019
3:26 PM | Audentes Therapeutics (Issuer)
Conner Edward R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities |  |
07/17/2019
3:24 PM | Audentes Therapeutics (Issuer)
Conner Edward R. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/26/2019
3:07 PM | Audentes Therapeutics (Issuer)
LANGE LOUIS G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2019
3:42 PM | Audentes Therapeutics (Issuer)
PRASAD SUYASH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2019
3:41 PM | Audentes Therapeutics (Issuer)
Patterson Matthew R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2019
3:41 PM | Audentes Therapeutics (Issuer)
Holles Natalie C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2019
3:40 PM | Audentes Therapeutics (Issuer)
Soloway Thomas P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2019
3:30 PM | Audentes Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2019
3:02 PM | Audentes Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2019
3:42 PM | Audentes Therapeutics (Issuer)
PRASAD SUYASH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2019
8:30 PM | Audentes Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2019
3:03 PM | Audentes Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2019
1:15 PM | Audentes Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2019
3:30 PM | Audentes Therapeutics (Filer)
| Form DEFA14A
| |
04/26/2019
3:30 PM | Audentes Therapeutics (Filer)
| Form DEF 14A
| |
04/08/2019
6:11 AM | Audentes Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2019
4:54 PM | Audentes Therapeutics (Issuer)
Meltz Mark A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2019
4:53 PM | Audentes Therapeutics (Issuer)
Meltz Mark A (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/27/2019
4:03 PM | Audentes Therapeutics (Issuer)
LANGE LOUIS G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2019
4:16 PM | Audentes Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2019
3:32 PM | Audentes Therapeutics (Issuer)
PRASAD SUYASH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2019
3:31 PM | Audentes Therapeutics (Issuer)
Patterson Matthew R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2019
4:22 PM | Audentes Therapeutics (Subject)
Partner Fund Management, L.P. (Filed by)
| Form SC 13G/A
| |
02/14/2019
12:51 PM | Audentes Therapeutics (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
| Form SC 13G/A
| |
02/12/2019
8:42 AM | Audentes Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A
| |
02/08/2019
4:50 PM | Audentes Therapeutics (Issuer)
Patterson Matthew R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2019
4:29 PM | Audentes Therapeutics (Issuer)
Soloway Thomas P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2019
4:28 PM | Audentes Therapeutics (Issuer)
Smith Julie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2019
4:27 PM | Audentes Therapeutics (Issuer)
Schuetz Thomas J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2019
4:25 PM | Audentes Therapeutics (Issuer)
PRASAD SUYASH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2019
4:23 PM | Audentes Therapeutics (Issuer)
Morrison Scott W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2019
4:22 PM | Audentes Therapeutics (Issuer)
LANGE LOUIS G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2019
4:21 PM | Audentes Therapeutics (Issuer)
Jarrett Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2019
4:20 PM | Audentes Therapeutics (Issuer)
Holles Natalie C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2019
4:20 PM | Audentes Therapeutics (Issuer)
Goldberg Mark Alan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2019
6:28 PM | Audentes Therapeutics (Issuer)
Holles Natalie C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2019
3:46 PM | Audentes Therapeutics (Issuer)
Mosbrooker Eric (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/27/2018
4:43 PM | Audentes Therapeutics (Issuer)
LANGE LOUIS G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2018
3:39 PM | Audentes Therapeutics (Issuer)
Patterson Matthew R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2018
5:41 PM | Audentes Therapeutics (Issuer)
NEWMAN MARY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2018
5:37 PM | Audentes Therapeutics (Issuer)
PRASAD SUYASH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2018
5:34 PM | Audentes Therapeutics (Issuer)
LANGE LOUIS G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2018
4:00 PM | Audentes Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/06/2018
3:15 PM | Audentes Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/29/2018
3:07 PM | Audentes Therapeutics (Subject)
Partner Fund Management, L.P. (Filed by)
| Form SC 13G
| |
10/11/2018
3:24 PM | Audentes Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2018
3:15 PM | Audentes Therapeutics (Filer)
| Form 424B5
| |
10/10/2018
9:03 AM | Audentes Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A
| |
10/09/2018
3:28 PM | Audentes Therapeutics (Filer)
| Form 424B5
| |
10/05/2018
7:05 AM | Audentes Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2018
6:05 PM | Audentes Therapeutics (Issuer)
PRASAD SUYASH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2018
6:04 PM | Audentes Therapeutics (Issuer)
Patterson Matthew R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2018
6:03 PM | Audentes Therapeutics (Issuer)
GRAY JOHN T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/26/2018
6:00 PM | Audentes Therapeutics (Issuer)
LANGE LOUIS G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2018
5:12 PM | Audentes Therapeutics (Issuer)
Patterson Matthew R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2018
6:01 PM | Audentes Therapeutics (Issuer)
Patterson Matthew R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2018
9:02 AM | Audentes Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A
| |
08/10/2018
3:30 PM | Audentes Therapeutics (Filer)
| Form 10-Q/A
| |
08/10/2018
3:20 PM | Audentes Therapeutics (Filer)
| Form 10-K/A
| |
08/07/2018
5:05 AM | Audentes Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2018
7:24 PM | Audentes Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/05/2018
5:35 PM | Audentes Therapeutics (Issuer)
PRASAD SUYASH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2018
5:34 PM | Audentes Therapeutics (Issuer)
Patterson Matthew R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2018
5:52 PM | Audentes Therapeutics (Issuer)
NEWMAN MARY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2018
5:51 PM | Audentes Therapeutics (Issuer)
LANGE LOUIS G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2018
6:11 PM | Audentes Therapeutics (Issuer)
Nagler David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2018
4:24 PM | Audentes Therapeutics (Issuer)
Smith Julie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2018
4:23 PM | Audentes Therapeutics (Issuer)
Schuetz Thomas J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2018
4:23 PM | Audentes Therapeutics (Issuer)
PARMAR KUSH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2018
4:22 PM | Audentes Therapeutics (Issuer)
Morrison Scott W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2018
4:21 PM | Audentes Therapeutics (Issuer)
LANGE LOUIS G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2018
4:21 PM | Audentes Therapeutics (Issuer)
Jarrett Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2018
4:20 PM | Audentes Therapeutics (Issuer)
Goldberg Mark Alan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2018
4:15 PM | Audentes Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2018
3:48 PM | Audentes Therapeutics (Issuer)
Holles Natalie C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2018
5:13 PM | Audentes Therapeutics (Issuer)
Patterson Matthew R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2018
10:31 AM | Audentes Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2018
3:16 PM | Audentes Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2018
7:08 AM | Audentes Therapeutics (Issuer)
Holles Natalie C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2018
7:05 AM | Audentes Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2018
12:36 PM | Audentes Therapeutics (Filer)
| Form CT ORDER
| |
04/04/2018
8:01 PM | Audentes Therapeutics (Issuer)
Patterson Matthew R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2018
8:06 PM | Audentes Therapeutics (Issuer)
NEWMAN MARY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2018
7:23 PM | Audentes Therapeutics (Issuer)
PRASAD SUYASH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2018
3:52 PM | Audentes Therapeutics (Filer)
| Form S-3ASR
| |
03/28/2018
8:12 PM | Audentes Therapeutics (Issuer)
PRASAD SUYASH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2018
8:11 PM | Audentes Therapeutics (Issuer)
LANGE LOUIS G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2018
5:16 PM | Audentes Therapeutics (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP IV LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/09/2018
4:26 PM | Audentes Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/08/2018
3:23 PM | Audentes Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2018
4:53 PM | Audentes Therapeutics (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP IV LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2018
12:07 PM | Audentes Therapeutics (Subject)
Sofinnova Venture Partners IX, L.P. (Filed by)
| Form SC 13G/A
| |
02/14/2018
7:46 AM | Audentes Therapeutics (Subject)
Flynn James E (Filed by)
| Form SC 13G/A
| |
02/13/2018
3:03 PM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Audentes Therapeutics (Subject)
| Form SC 13G/A
| |
02/13/2018
2:08 PM | Audentes Therapeutics (Subject)
Versant Side Fund IV, L.P. (Filed by)
| Form SC 13G/A
| |
02/13/2018
8:34 AM | Audentes Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A
| |
02/12/2018
8:59 AM | Audentes Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G
| |
02/08/2018
12:56 PM | 5AM VENTURES III, L.P. (Filed by)
Audentes Therapeutics (Subject)
| Form SC 13G/A
| |
01/25/2018
3:14 PM | Audentes Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/25/2018
3:08 PM | Audentes Therapeutics (Filer)
| Form 424B4
| |
